AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

XTL Biopharmaceuticals Ltd.

Regulatory Filings Jun 5, 2007

7116_rns_2007-06-05_58f4690b-b40d-469e-8311-9e1f9aa01e08.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________

C001��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996379Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: [email protected] of transmission: 05/06/2007              Time of broadcast: 13:04 13:03:50

Reference: 2007-02-417257

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
2006 Annual Report - Full Report
XTLAR200601_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 28/02/2007
- - -
Name of the Signatory: : Kantor Ronen , , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.